XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Defined Benefit Pension Plans
Cumulative Translation Adjustment
Deferred Gains (Losses) on Derivatives
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2019   75,471,562              
Stockholders' equity, beginning of period at Dec. 31, 2019 $ 2,907.0 $ 0.8 $ 4.7 $ 4,443.5 $ (1,595.2) $ (296.4) $ (1,297.5) $ (1.3) $ 53.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 419.8     427.1         (7.3)
Payment of dividends to shareholders (48.0)     (48.0)          
Issuance of non-employee director restricted stock (in shares)   19,862              
Issuance of non-employee director restricted stock 1.1   1.1            
Issuance of stock awards (in shares)   374,212              
Issuance of stock awards (15.7)   (7.3) (8.4)          
SSARs exercised (in shares)   66,736              
SSARs exercised (4.2)   (4.1) (0.1)          
Stock compensation 36.5   39.9 (3.4)          
Investment by noncontrolling interests 0.2               0.2
Distribution to noncontrolling interest (3.3)               (3.3)
Changes in/Sale of noncontrolling interest (0.5)               (0.5)
Purchases and retirement of common stock (in shares)   (970,141)              
Purchases and retirement of common stock (55.0)   (3.4) (51.6)          
Defined benefit pension plans, net of taxes:                  
Prior service (cost) credit arising during the year 0.3       0.3 0.3      
Net (gain) loss recognized due to settlement 0.3       0.3 0.3      
Net loss recognized due to curtailment 0.0                
Net actuarial gain (loss) arising during the year (32.7)       (32.7) (32.7)      
Amortization of prior service cost included in net periodic pension cost 2.1       2.1 2.1      
Amortization of net actuarial losses included in net periodic pension cost 13.1       13.1 13.1      
Deferred gains and losses on derivatives, net (1.2)       (1.2)     (1.2)  
Foreign currency translation adjustments (201.8)       (197.5)   (197.5)   (4.3)
Ending balance (in shares) at Dec. 31, 2020   74,962,231              
Stockholders' equity, end of period at Dec. 31, 2020 3,018.0 $ 0.8 30.9 4,759.1 (1,810.8) (313.3) (1,495.0) (2.5) 38.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 901.5     897.0         4.5
Payment of dividends to shareholders (358.5)     (358.5)          
Issuance of non-employee director restricted stock (in shares)   8,912              
Issuance of non-employee director restricted stock 1.3   1.3            
Issuance of stock awards (in shares)   362,034              
Issuance of stock awards (29.5)   (29.5)            
SSARs exercised (in shares)   60,339              
SSARs exercised (5.4)   (5.4)            
Stock compensation 26.1   26.1            
Distribution to noncontrolling interest (3.6)               (3.6)
Investment by noncontrolling interests (10.6)               (10.6)
Purchases and retirement of common stock (in shares)   (952,204)              
Purchases and retirement of common stock (135.0) $ (0.1) (19.5) (115.4)          
Defined benefit pension plans, net of taxes:                  
Prior service (cost) credit arising during the year 10.0       10.0 10.0      
Net (gain) loss recognized due to settlement 0.1       0.1 0.1      
Net loss recognized due to curtailment 6.3       6.3 6.3      
Net actuarial gain (loss) arising during the year 53.6       53.6 53.6      
Amortization of prior service cost included in net periodic pension cost 0.6       0.6 0.6      
Amortization of net actuarial losses included in net periodic pension cost 12.3       12.3 12.3      
Deferred gains and losses on derivatives, net 2.1       2.1     2.1  
Foreign currency translation adjustments (45.5)       (45.1)   (45.1)   (0.4)
Ending balance (in shares) at Dec. 31, 2021   74,441,312              
Stockholders' equity, end of period at Dec. 31, 2021 3,443.8 $ 0.7 3.9 5,182.2 (1,770.9) (230.4) (1,540.1) (0.4) 27.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 874.7     889.6         (14.9)
Payment of dividends to shareholders (404.3)     (404.3)          
Issuance of non-employee director restricted stock (in shares)   10,301              
Issuance of non-employee director restricted stock 1.5   1.5            
Issuance of stock awards (in shares)   250,719              
Issuance of stock awards (19.4)   (6.5) (12.9)          
SSARs exercised (in shares)   12,307              
SSARs exercised (1.2)   (1.2)            
Stock compensation 32.5   32.5            
Distribution to noncontrolling interest (13.8)               (13.8)
Noncontrolling Interest, Increase from Subsidiary Equity Issuance 0.1               0.1
Purchases and retirement of common stock (in shares)   (113,824)              
Defined benefit pension plans, net of taxes:                  
Prior service (cost) credit arising during the year (19.1)       (19.1) (19.1)      
Net (gain) loss recognized due to settlement (0.4)       (0.4) (0.4)      
Net loss recognized due to curtailment 0.0                
Net actuarial gain (loss) arising during the year 12.3       12.3 12.3      
Amortization of prior service cost included in net periodic pension cost 0.0                
Amortization of net actuarial losses included in net periodic pension cost 6.4       6.4 6.4      
Deferred gains and losses on derivatives, net (0.5)       (0.5)     (0.5)  
Foreign currency translation adjustments (30.0)       (30.9)   (30.9)   0.9
Ending balance (in shares) at Dec. 31, 2022   74,600,815              
Stockholders' equity, end of period at Dec. 31, 2022 $ 3,882.6 $ 0.7 $ 30.2 $ 5,654.6 $ (1,803.1) $ (231.2) $ (1,571.0) $ (0.9) $ 0.2